[fa icon="calendar'] January 28, 2009 / posted in Dr. Mark Bates, Stents, SurModics, Innovation
Agreement Represents Second Stent Development Collaboration Between SurModics and Nexeon MedSystems
EDEN PRAIRIE, Minn. & CHARLESTON, W. Va.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to t
[fa icon="calendar'] October 23, 2008 / posted in Stents, SurModics, Nexeon
Paragon Intellectual Properties, LLC, announced that it has restructured the company, moving from a limited liability company with seven subsidiaries to a single C-corporation to form Nexeon MedSystems, Inc. This restructuring was undertaken to prepare for pending clin
[fa icon="calendar'] October 8, 2008 / posted in Dr. Mark Bates, Stents, Clinical Trials, WVU School of Medicine
New Class of Stent Could Offer Non-DES Solution to Restenosis and Late Stent Thrombosis
CHARLESTON, W.Va. & CARLSBAD, Calif.--(BUSINESS WIRE)--Nexeon MedSystems, Inc., a developer of medical technology for the treatment of cardiovascular disease, announced today that t
Nexeon is a bioelectronics company developing and manufacturing medical devices and the software platforms that support the remote management of these devices.
[fa icon="phone"]
[fa icon="envelope"] [email protected]
[fa icon="home"] 1708 Jaggie Fox Way, Lexington KY 40511